Submission for OMB Review; 30-Day Comment Request; Recruitment and Screening for the Insight Into Determination of Exceptional Aging and Longevity (IDEAL) Study, 44811-44812 [2014-18145]

Download as PDF Federal Register / Vol. 79, No. 148 / Friday, August 1, 2014 / Notices Please make sure that the FDA post office box number (P.O. Box 979107) is written on the check, bank draft, or postal money order. Wire transfer payment may also be used. Please reference your unique user fee ID number when completing your transfer. The originating financial institution may charge a wire transfer fee. Please ask your financial institution about the fee and add it to your payment to ensure that your fee is fully paid. The account information for wire transfers is as follows: New York Federal Reserve Bank, U.S. Department of the Treasury, TREAS NYC, 33 Liberty St., New York, NY 10045, Acct. No.: 75060099, Routing No.: 021030004, SWIFT: FRNYUS33, Beneficiary: FDA, 8455 Colesville Rd., 14th Floor, Silver Spring, MD 20993– 0002. Application fees can also be paid online with an electronic check (ACH). FDA has partnered with the U.S. Department of the Treasury to use Pay.gov, a Web-based payment application, for online electronic payment. The Pay.gov feature is available on the FDA Web site after the user fee ID number is generated. The tax identification number of FDA is 53–0196965. B. Establishment and Product Fees FDA will issue invoices for establishment and product fees for FY 2015 under the new fee schedule in August 2014. Payment will be due on October 1, 2014. FDA will issue invoices in November 2015 for any products and establishments subject to fees for FY 2015 that qualify for fee assessments after the August 2014 billing. Dated: July 25, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014–18113 Filed 7–31–14; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health tkelley on DSK3SPTVN1PROD with NOTICES Notice of Correction The National Institutes of Health NIH published in the Federal Register on July 18, 2014 a notice titled ‘‘Proposed Collection; 60-Day Comment Request; A Generic Submission for Formative Research, Pre-Testing, Stakeholder Measures and Advocate Forms at NCI’’ [79 FR 42023]. The notice contained an incorrect email address for Kelley Landy, Acting Director of the Office of VerDate Mar<15>2010 22:09 Jul 31, 2014 Jkt 232001 Advocacy Relations. The correct email address is kelley.landy@nih.gov. Dated: July 28, 2014. Cynthia Chaves, NIH Federal Register Liaison. [FR Doc. 2014–18087 Filed 7–31–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Recruitment and Screening for the Insight Into Determination of Exceptional Aging and Longevity (IDEAL) Study Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on April 2, 2014, Vol. 79, page 18569 and allowed 60days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute on Aging (NIA), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Luigi Ferrucci, M.D., Ph.D., NIA Clinical Research Branch, Harbor Hospital, 5th Floor, 3001 S. Hanover, Baltimore, MD 21225 or call non-tollfree number (410) 350–3936 or Email your request, including your address to: Ferruccilu@grc.nia.nih.gov. Formal SUMMARY: PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 44811 requests for additional plans and instruments must be requested in writing. Proposed Collection: Recruitment and Screening for the Insight into Determination of Exceptional Aging and Longevity (IDEAL) Study (OMB#: 0925– 0631). National Institute on Aging (NIA), National Institutes of Health (NIH). Need and Use of Information Collection Longevity combined with good health and functionality at the end of life represents a common goal. Although research has examined correlates of long life and functional decline, we still know relatively little about why certain individuals live in excellent health into their eighties while others succumb to failing health at much younger ages. Understanding the mechanisms important to ideal aging may provide new opportunity for health promotion and disability prevention is this rapidly growing segment of the population. The purpose of IDEAL (Insight into the Determinants of Exceptional Aging and Longevity) is to recruit into the Baltimore Longitudinal Study on Aging (BLSA) exceptionally long lived and healthy individuals and to learn what makes them so resilient and resistant to disease and disability, and to identify potential interventions that may contribute to the IDEAL condition. By enrolling the IDEAL cohort in the BLSA their biologic, physiologic, behavioral and functional characteristics will be evaluated using the same methods used with the current cohort who will serve as a type of control group. The first aim is to identify factors and characteristics that distinguish IDEAL from non-IDEAL individuals. We intend to compare the two groups to identify factors that discriminate IDEAL aging from nonIDEAL aging individuals. The second aim is to identify physiological, environmental and behavioral characteristics that are risk factors for losing the IDEAL condition over several years or longer. We postulate that the mechanisms of extreme longevity probably differ from those associated with delay or escape from disease and disability. As is customary in the BLSA, we plan to follow this cohort for life with yearly visits. This is a request for OMB to approve a reinstatement with change of Recruitment and Screening for the Insight into Determination of Exceptional Aging and Longevity (IDEAL) Study for 3 years. OMB approval is requested for 3 years. There is no annualized cost to respondents. The total estimated annualized burden hours are 333. E:\FR\FM\01AUN1.SGM 01AUN1 44812 Federal Register / Vol. 79, No. 148 / Friday, August 1, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Individuals Individuals Individuals Individuals ............................. ............................. ............................. ............................. Estimated annual number of respondents Form name Recruitment Phone Screen Part 1 ............... Recruitment Phone Screen Part 2 ............... Pre-Visit mailing/Consent ............................. Screening Exam Visit ................................... Dated: July 23, 2014. Jessica Schwartz, NIA Project Clearance Liaison, National Institutes of Health. 500 200 100 100 (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS). Dated: July 25, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–18145 Filed 7–31–14; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2014–18071 Filed 7–31–14; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Mental Health; Notice of Closed Meeting tkelley on DSK3SPTVN1PROD with NOTICES Jkt 232001 1 1 1 1 Total annual burden hours 10/60 10/60 10/60 2 83 33 17 200 limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS). Dated: July 25, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–18070 Filed 7–31–14; 8:45 am] BILLING CODE 4140–01–P Name of Committee: National Advisory Mental Health Council. Date: August 26, 2014. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C/D, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Jane A. Steinberg, Ph.D., Director, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Bethesda, MD 20892– 9609, 301–443–5047. Information is also available on the Institute’s/Center’s home page: http:// www.nimh.nih.gov/about/advisory-boardsand-groups/namhc/index.shtml, where an agenda and any additional information for the meeting will be posted when available. 22:09 Jul 31, 2014 Average time per response (in hours) National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Mental Health Council. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Mar<15>2010 Number of responses per respondent National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Additional SUDEP CWoW Review. Date: August 4, 2014. Time: 5:00 p.m. to 11:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: William C. Benzing, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301–496– 0660, benzingw@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cardiovascular Development and Molecular Genetics. Date: August 26, 2014. Time: 1:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Delvin Knight, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194 MSC 4128, Bethesda, MD 20892–7814, 301.435.1850, knightdr@csr.nih.gov. E:\FR\FM\01AUN1.SGM 01AUN1

Agencies

[Federal Register Volume 79, Number 148 (Friday, August 1, 2014)]
[Notices]
[Pages 44811-44812]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18145]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Recruitment 
and Screening for the Insight Into Determination of Exceptional Aging 
and Longevity (IDEAL) Study

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH), has 
submitted to the Office of Management and Budget (OMB) a request for 
review and approval of the information collection listed below. This 
proposed information collection was previously published in the Federal 
Register on April 2, 2014, Vol. 79, page 18569 and allowed 60-days for 
public comment. No public comments were received. The purpose of this 
notice is to allow an additional 30 days for public comment. The 
National Institute on Aging (NIA), National Institutes of Health, may 
not conduct or sponsor, and the respondent is not required to respond 
to, an information collection that has been extended, revised, or 
implemented on or after October 1, 1995, unless it displays a currently 
valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT:  To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: Luigi Ferrucci, M.D., Ph.D., NIA Clinical 
Research Branch, Harbor Hospital, 5th Floor, 3001 S. Hanover, 
Baltimore, MD 21225 or call non-toll-free number (410) 350-3936 or 
Email your request, including your address to: 
Ferruccilu@grc.nia.nih.gov. Formal requests for additional plans and 
instruments must be requested in writing.
    Proposed Collection: Recruitment and Screening for the Insight into 
Determination of Exceptional Aging and Longevity (IDEAL) Study 
(OMB: 0925-0631). National Institute on Aging (NIA), National 
Institutes of Health (NIH).

Need and Use of Information Collection

    Longevity combined with good health and functionality at the end of 
life represents a common goal. Although research has examined 
correlates of long life and functional decline, we still know 
relatively little about why certain individuals live in excellent 
health into their eighties while others succumb to failing health at 
much younger ages. Understanding the mechanisms important to ideal 
aging may provide new opportunity for health promotion and disability 
prevention is this rapidly growing segment of the population.
    The purpose of IDEAL (Insight into the Determinants of Exceptional 
Aging and Longevity) is to recruit into the Baltimore Longitudinal 
Study on Aging (BLSA) exceptionally long lived and healthy individuals 
and to learn what makes them so resilient and resistant to disease and 
disability, and to identify potential interventions that may contribute 
to the IDEAL condition. By enrolling the IDEAL cohort in the BLSA their 
biologic, physiologic, behavioral and functional characteristics will 
be evaluated using the same methods used with the current cohort who 
will serve as a type of control group. The first aim is to identify 
factors and characteristics that distinguish IDEAL from non-IDEAL 
individuals. We intend to compare the two groups to identify factors 
that discriminate IDEAL aging from non-IDEAL aging individuals. The 
second aim is to identify physiological, environmental and behavioral 
characteristics that are risk factors for losing the IDEAL condition 
over several years or longer. We postulate that the mechanisms of 
extreme longevity probably differ from those associated with delay or 
escape from disease and disability. As is customary in the BLSA, we 
plan to follow this cohort for life with yearly visits. This is a 
request for OMB to approve a reinstatement with change of Recruitment 
and Screening for the Insight into Determination of Exceptional Aging 
and Longevity (IDEAL) Study for 3 years.
    OMB approval is requested for 3 years. There is no annualized cost 
to respondents. The total estimated annualized burden hours are 333.

[[Page 44812]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                     Estimated       Number of     Average time
      Type of respondent            Form name      annual number   responses per   per response    Total annual
                                                  of respondents    respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Individuals...................  Recruitment                  500               1           10/60              83
                                 Phone Screen
                                 Part 1.
Individuals...................  Recruitment                  200               1           10/60              33
                                 Phone Screen
                                 Part 2.
Individuals...................  Pre-Visit                    100               1           10/60              17
                                 mailing/Consent.
Individuals...................  Screening Exam               100               1               2             200
                                 Visit.
----------------------------------------------------------------------------------------------------------------


    Dated: July 23, 2014.
Jessica Schwartz,
NIA Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-18145 Filed 7-31-14; 8:45 am]
BILLING CODE 4140-01-P